NDC 66733-958-23
ERBITUX 2 mg/mL
cetuximab · SOLUTION
Erbitux (cetuximab) is an intravenous medication that works by blocking epidermal growth factor receptors on cancer cells to slow or stop their growth. It is used to treat certain types of head and neck cancer and colorectal cancer.
Key Facts
- Brand Name
- ERBITUX
- Generic Name
- cetuximab
- NDC Code (Package)
66733-958-23- NDC Code (Product)
66733-958- Manufacturer
- ImClone LLC
- Strength
- 2 mg/mL
- Dosage Form
- SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA125084
- Drug Class
- Epidermal Growth Factor Receptor Antagonist [EPC]
- Marketing Start
- 10/02/2007
Recall History
No Recall HistoryView Full Drug Page
ERBITUX — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.